Copyright Reports & Markets. All rights reserved.

Dynamics in Post-pandemic Global Anthrax Vaccines Industry: Supply and Demand, Markets and Prices 2021-2027

Buy now

Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global Anthrax Vaccines Market Status and Forecast (2016-2027)
      • 1.3.2 Global Anthrax Vaccines Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global Anthrax Vaccines Supply by Company

    • 2.1 Global Anthrax Vaccines Sales Volume by Company
    • 2.2 Global Anthrax Vaccines Sales Value by Company
    • 2.3 Global Anthrax Vaccines Price by Company
    • 2.4 Anthrax Vaccines Production Location and Sales Area of Main Manufacturers
    • 2.5 Trend of Concentration Rate

    3 Global and Regional Anthrax Vaccines Market Status by Category

    • 3.1 Anthrax Vaccines Category Introduction
      • 3.1.1 Live Vaccines
      • 3.1.2 Cell free PA Vaccines
    • 3.2 Global Anthrax Vaccines Market by Category
      • 3.2.1 Global Anthrax Vaccines Sales Volume by Category (2016-2021)
      • 3.2.2 Global Anthrax Vaccines Sales Value by Category (2016-2021)
      • 3.2.3 Global Anthrax Vaccines Price by Category (2016-2021)
    • 3.3 North America: by Category
    • 3.4 Europe: by Category
    • 3.5 Asia Pacific: by Category
    • 3.6 Central & South America: by Category
    • 3.7 Middle East & Africa: by Category

    4 Global and Regional Anthrax Vaccines Market Status by End User/Segment

    • 4.1 Anthrax Vaccines Segment by End User/Segment
      • 4.1.1 Human Use
      • 4.1.2 Animal Use
    • 4.2 Global Anthrax Vaccines Market by End User/Segment
      • 4.2.1 Global Anthrax Vaccines Sales Volume by End User/Segment (2016-2021)
      • 4.2.2 Global Anthrax Vaccines Sales Value by End User/Segment (2016-2021)
      • 4.2.3 Global Anthrax Vaccines Price by End User/Segment (2016-2021)
    • 4.3 North America: by End User/Segment
    • 4.4 Europe: by End User/Segment
    • 4.5 Asia Pacific: by End User/Segment
    • 4.6 Central & South America: by End User/Segment
    • 4.7 Middle East & Africa: by End User/Segment

    5 Global Anthrax Vaccines Market Status by Region

    • 5.1 Global Anthrax Vaccines Market by Region
      • 5.1.1 Global Anthrax Vaccines Sales Volume by Region
      • 5.1.2 Global Anthrax Vaccines Sales Value by Region
    • 5.2 North America Anthrax Vaccines Market Status
    • 5.3 Europe Anthrax Vaccines Market Status
    • 5.4 Asia Pacific Anthrax Vaccines Market Status
    • 5.5 Central & South America Anthrax Vaccines Market Status
    • 5.6 Middle East & Africa Anthrax Vaccines Market Status

    6 North America Anthrax Vaccines Market Status

    • 6.1 North America Anthrax Vaccines Market by Country
      • 6.1.1 North America Anthrax Vaccines Sales Volume by Country (2016-2021)
      • 6.1.2 North America Anthrax Vaccines Sales Value by Country (2016-2021)
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe Anthrax Vaccines Market Status

    • 7.1 Europe Anthrax Vaccines Market by Country
      • 7.1.1 Europe Anthrax Vaccines Sales Volume by Country (2016-2021)
      • 7.1.2 Europe Anthrax Vaccines Sales Value by Country (2016-2021)
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific Anthrax Vaccines Market Status

    • 8.1 Asia Pacific Anthrax Vaccines Market by Country
      • 8.1.1 Asia Pacific Anthrax Vaccines Sales Volume by Country (2016-2021)
      • 8.1.2 Asia Pacific Anthrax Vaccines Sales Value by Country (2016-2021)
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America Anthrax Vaccines Market Status

    • 9.1 Central & South America Anthrax Vaccines Market by Country
      • 9.1.1 Central & South America Anthrax Vaccines Sales Volume by Country (2016-2021)
      • 9.1.2 Central & South America Anthrax Vaccines Sales Value by Country (2016-2021)
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa Anthrax Vaccines Market Status

    • 10.1 Middle East & Africa Anthrax Vaccines Market by Country
      • 10.1.1 Middle East & Africa Anthrax Vaccines Sales Volume by Country (2016-2021)
      • 10.1.2 Middle East & Africa Anthrax Vaccines Sales Value by Country (2016-2021)
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Sales Channel, Distributors and Buyers

    • 11.1 Sales Channel
      • 11.1.1 Direct Sales
      • 11.1.2 Channel Sales
    • 11.2 Anthrax Vaccines Distributors
    • 11.3 Anthrax Vaccines Buyers

    12 Global Anthrax Vaccines Market Forecast by Category and by End User/Segment

    • 12.1 Global Anthrax Vaccines Sales Volume and Sales Value Forecast (2022-2027)
    • 12.2 Global Anthrax Vaccines Forecast by Category
      • 12.2.1 Global Anthrax Vaccines Sales Volume Forecast by Category
      • 12.2.2 Global Anthrax Vaccines Sales Value Forecast by Category
      • 12.2.3 Global Anthrax Vaccines Price Forecast by Category
    • 12.3 Global Anthrax Vaccines Forecast by End User/Segment
      • 12.3.1 Global Anthrax Vaccines Sales Volume Forecast by End User/Segment
      • 12.3.2 Global Anthrax Vaccines Sales Value Forecast by End User/Segment
      • 12.3.3 Global Anthrax Vaccines Price Forecast by End User/Segment

    13 Global Anthrax Vaccines Market Forecast by Region/Country

    • 13.1 Global Anthrax Vaccines Market Forecast by Region (2022-2027)
      • 13.1.1 Global Anthrax Vaccines Sales Volume Forecast by Region (2022-2027)
      • 13.1.2 Global Anthrax Vaccines Sales Value Forecast by Region (2022-2027)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 Emergent BioSolutions
      • 14.1.1 Company Information
      • 14.1.2 Anthrax Vaccines Product Introduction
      • 14.1.3 Emergent BioSolutions Anthrax Vaccines Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.1.4 Contact Information
    • 14.2 Merial
      • 14.2.1 Company Information
      • 14.2.2 Anthrax Vaccines Product Introduction
      • 14.2.3 Merial Anthrax Vaccines Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.2.4 Contact Information
    • 14.3 IVPM
      • 14.3.1 Company Information
      • 14.3.2 Anthrax Vaccines Product Introduction
      • 14.3.3 IVPM Anthrax Vaccines Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.3.4 Contact Information
    • 14.4 Bayer Sanidad Animal
      • 14.4.1 Company Information
      • 14.4.2 Anthrax Vaccines Product Introduction
      • 14.4.3 Bayer Sanidad Animal Anthrax Vaccines Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.4.4 Contact Information
    • 14.5 Merck
      • 14.5.1 Company Information
      • 14.5.2 Anthrax Vaccines Product Introduction
      • 14.5.3 Merck Anthrax Vaccines Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.5.4 Contact Information
    • 14.6 Indian Immunologicals
      • 14.6.1 Company Information
      • 14.6.2 Anthrax Vaccines Product Introduction
      • 14.6.3 Indian Immunologicals Anthrax Vaccines Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.6.4 Contact Information
    • 14.7 Zoetis
      • 14.7.1 Company Information
      • 14.7.2 Anthrax Vaccines Product Introduction
      • 14.7.3 Zoetis Anthrax Vaccines Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.7.4 Contact Information
    • 14.8 CDV
      • 14.8.1 Company Information
      • 14.8.2 Anthrax Vaccines Product Introduction
      • 14.8.3 CDV Anthrax Vaccines Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.8.4 Contact Information
    • 14.9 PharmAthene
      • 14.9.1 Company Information
      • 14.9.2 Anthrax Vaccines Product Introduction
      • 14.9.3 PharmAthene Anthrax Vaccines Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.9.4 Contact Information
    • 14.10 Tiankang
      • 14.10.1 Company Information
      • 14.10.2 Anthrax Vaccines Product Introduction
      • 14.10.3 Tiankang Anthrax Vaccines Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.10.4 Contact Information
    • 14.11 CVCRI
    • 14.12 Vecol
    • 14.13 Prondil
    • 14.14 Biogénesis-Bago
    • 14.15 Colorado Serum
    • 14.16 Rosenbusch
    • 14.17 CAVAC
    • 14.18 Agrovet

    15 Conclusion

    Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Anthrax Vaccines market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Anthrax Vaccines market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.

    Segmented by Category
    Live Vaccines
    Cell free PA Vaccines

    Segmented by End User/Segment
    Human Use
    Animal Use

    Segmented by Country
    North America
    United States
    Canada
    Mexico
    Europe
    Germany
    France
    UK
    Italy
    Russia
    Spain
    Asia Pacific
    China
    Japan
    Korea
    Southeast Asia
    India
    Australasia
    Central & South America
    Brazil
    Argentina
    Colombia
    Middle East & Africa
    Iran
    Israel
    Turkey
    South Africa
    Saudi Arabia

    Key manufacturers included in this survey
    Emergent BioSolutions
    Merial
    IVPM
    Bayer Sanidad Animal
    Merck
    Indian Immunologicals
    Zoetis
    CDV
    PharmAthene
    Tiankang
    CVCRI
    Vecol
    Prondil
    Biogénesis-Bago
    Colorado Serum
    Rosenbusch
    CAVAC
    Agrovet

    Buy now